P-195 A cohort of patients (pt) with HER2-positive (HER2+) advanced gastroesophageal cancer (aGEC) treated at our institution after a decade of tailored targeted therapy

Autor: Pous Badia, A., Ferrando Díez, A., Hierro Carbó, C., España Fernández, S., Plaja Salarich, A., Notario Rincon, L., Layos Romero, L., Manzano Mozo, J., Font Pous, A., Linares, J., Álvaro Pardo, M., Calsina Berna, A., Sendrós Madroño, M., Hernandez Marfil, A., Riquelme Olivares, M., López Martos, R., Colan Hernández, J., Garsot Savall, E., Caro Gallarín, M., Barluenga Torres, E., Munné, M., Bugés Sánchez, C.
Zdroj: In Annals of Oncology June 2022 33 Supplement 4:S319-S319
Databáze: ScienceDirect